Long-Term Reduction of C-Reactive Protein by LDL Apheresis

    October 2002 in “ Atherosclerosis Supplements
    Studysummary LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →